AI assistant
Sending…
ELI LILLY & Co — Director's Dealing 2014
Dec 12, 2014
29745_dirs_2014-12-12_5c19c656-590a-4f77-9f6a-f02d54ac4a66.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LILLY ELI & CO (LLY)
CIK: 0000059478
Period of Report: 2014-12-10
Reporting Person: Conterno Enrique A (Sr. VP & Pres., Lilly Diabetes)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-12-10 | Common Stock | M | 7101 | $55.65 | Acquired | 79837 | Direct |
| 2014-12-10 | Common Stock | F | 6046 | $72.21 | Disposed | 73791 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-12-10 | Employee stock option 2/05 (right to buy) | $55.65 | M | 7101 | Disposed | 2015-02-10 | Common Stock (7101.0) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 4681 | Indirect |
More from ELI LILLY & Co
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 11
Regulatory Filings
2026
May 8
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 6
Regulatory Filings
2026
May 6
Major Shareholding Notification
2026
May 1
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 29